Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06940622 · ClinicalTrials.gov registry record · NA
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
A NA study of Recurrent Urinary Tract Infection and UTI, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06940622 is a NA study of Recurrent Urinary Tract Infection and UTI that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 90 participants, roughly in line with the 92-participant average among 4 other Recurrent Urinary Tract Infection trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06940622, a NA study of Recurrent Urinary Tract Infection and UTI, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection) prevention in post-menopausal women.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT D-Mannose
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2030-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06940622
The ClinicalTrials.gov registry entry for NCT06940622 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 92-participant average among 4 other Recurrent Urinary Tract Infection trials with a reported enrollment target. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Recurrent Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06940622 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06940622 about?
NCT06940622 is a clinical study titled "A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections". A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection) prevention in post-menopausal women.
What is the current status of trial NCT06940622?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-08-01. Estimated completion is 2030-09-30.
What conditions does trial NCT06940622 study?
This clinical trial studies the following conditions: Recurrent Urinary Tract Infection, UTI, Recurrent UTIs, Recurrent Urinary Tract Infections, Recurrent Urinary Tract Infections in Women.
What interventions are being tested in trial NCT06940622?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), D-Mannose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06940622?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06940622 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
RECRUITING · Phase 4
-
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
ACTIVE NOT RECRUITING · Phase 4
-
Chlorhexidine Lavage for Recurrent Urinary Tract Infection
ACTIVE NOT RECRUITING · Phase 4
-
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.